Private Equity In Healthcare: Increased Scrutiny From FTC, DOJ, And HHS
On March 5, 2024, the Federal Trade Commission (“FTC”), the Department of Justice (“DOJ”) Antitrust Division, and Department of Health and Human Services (“HHS”) announced that they are launching a “cross-government public inquiry into private equity and other corporations’ increasing control over health care.” This effort is another step by regulators in their increased scrutiny of private equity. The inquiry seeks to understand how private equity transactions in the healthcare field affect consolidation, as well as […]